124 related articles for article (PubMed ID: 22028439)
1. CDH16/Ksp-cadherin is expressed in the developing thyroid gland and is strongly down-regulated in thyroid carcinomas.
Calì G; Gentile F; Mogavero S; Pallante P; Nitsch R; Ciancia G; Ferraro A; Fusco A; Nitsch L
Endocrinology; 2012 Jan; 153(1):522-34. PubMed ID: 22028439
[TBL] [Abstract][Full Text] [Related]
2. Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid.
Lennartz M; Csomós H; Chirico V; Weidemann S; Gorbokon N; Menz A; Büscheck F; Hube-Magg C; Höflmayer D; Bernreuther C; Blessin NC; Lebok P; Sauter G; Steurer S; Burandt E; Dum D; Krech T; Simon R; Minner S; Jacobsen F; Clauditz TS; Luebke AM; Siraj AK; Al-Dayel F; Al-Kuraya KS; Hinsch A
Sci Rep; 2023 Aug; 13(1):12917. PubMed ID: 37558687
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibition modulates E-cadherin expression and suppresses migration and invasion of anaplastic thyroid cancer cells.
Catalano MG; Fortunati N; Pugliese M; Marano F; Ortoleva L; Poli R; Asioli S; Bandino A; Palestini N; Grange C; Bussolati B; Boccuzzi G
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1150-9. PubMed ID: 22563106
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the cell-cell adhesion protein, E-cadherin, in dog and human thyrocytes in vitro.
Brabant G; Hoang-Vu C; Behrends J; Cetin Y; Pötter E; Dumont JE; Maenhaut C
Endocrinology; 1995 Jul; 136(7):3113-9. PubMed ID: 7789339
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin: a differentiation marker in thyroid malignancies.
Brabant G; Hoang-Vu C; Cetin Y; Dralle H; Scheumann G; Mölne J; Hansson G; Jansson S; Ericson LE; Nilsson M
Cancer Res; 1993 Oct; 53(20):4987-93. PubMed ID: 8402689
[TBL] [Abstract][Full Text] [Related]
6. INSL-3 is expressed in human hyperplastic and neoplastic thyrocytes.
Hombach-Klonisch S; Hoang-Vu C; Kehlen A; Hinze R; Holzhausen HJ; Weber E; Fischer B; Dralle H; Klonisch T
Int J Oncol; 2003 May; 22(5):993-1001. PubMed ID: 12684664
[TBL] [Abstract][Full Text] [Related]
7. Study of gene expression in thyrotropin-stimulated thyroid cells by cDNA expression array: ID3 transcription modulating factor as an early response protein and tumor marker in thyroid carcinomas.
Deleu S; Savonet V; Behrends J; Dumont JE; Maenhaut C
Exp Cell Res; 2002 Sep; 279(1):62-70. PubMed ID: 12213214
[TBL] [Abstract][Full Text] [Related]
8. The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells.
Zhang Z; Liu ZB; Ren WM; Ye XG; Zhang YY
Int J Mol Med; 2012 Oct; 30(4):856-62. PubMed ID: 22797360
[TBL] [Abstract][Full Text] [Related]
9. An essential role for Pax8 in the transcriptional regulation of cadherin-16 in thyroid cells.
de Cristofaro T; Di Palma T; Fichera I; Lucci V; Parrillo L; De Felice M; Zannini M
Mol Endocrinol; 2012 Jan; 26(1):67-78. PubMed ID: 22135066
[TBL] [Abstract][Full Text] [Related]
10. Expression of M-cadherin protein in myogenic cells during prenatal mouse development and differentiation of embryonic stem cells in culture.
Rose O; Rohwedel J; Reinhardt S; Bachmann M; Cramer M; Rotter M; Wobus A; Starzinski-Powitz A
Dev Dyn; 1994 Nov; 201(3):245-59. PubMed ID: 7881128
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
[TBL] [Abstract][Full Text] [Related]
12. alpha B-crystallin is a cytoplasmic interaction partner of the kidney-specific cadherin-16.
Thedieck C; Kalbacher H; Kratzer U; Lammers R; Stevanovic S; Klein G
J Mol Biol; 2008 Apr; 378(1):145-53. PubMed ID: 18343407
[TBL] [Abstract][Full Text] [Related]
13. Let-7a down-regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (Dysadherin) gene.
Colamaio M; Calì G; Sarnataro D; Borbone E; Pallante P; Decaussin-Petrucci M; Nitsch L; Croce CM; Battista S; Fusco A
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2168-78. PubMed ID: 22965940
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin adhesion molecule and syndecan-1 expression in various thyroid pathologies.
Mitselou A; Ioachim E; Peschos D; Charalabopoulos K; Michael M; Agnantis NJ; Vougiouklakis T
Exp Oncol; 2007 Mar; 29(1):54-60. PubMed ID: 17431390
[TBL] [Abstract][Full Text] [Related]
15. Mutual regulation of TGF-β1, TβRII and ErbB receptors expression in human thyroid carcinomas.
Mincione G; Tarantelli C; Vianale G; Di Marcantonio MC; Cotellese R; Francomano F; Di Nicola M; Costantini E; Cichella A; Muraro R
Exp Cell Res; 2014 Sep; 327(1):24-36. PubMed ID: 24973511
[TBL] [Abstract][Full Text] [Related]
16. Expression of Ksp-cadherin during kidney development and in renal cell carcinoma.
Thedieck C; Kuczyk M; Klingel K; Steiert I; Müller CA; Klein G
Br J Cancer; 2005 Jun; 92(11):2010-7. PubMed ID: 15886705
[TBL] [Abstract][Full Text] [Related]
17. Conditional inactivation of the E-cadherin gene in thyroid follicular cells affects gland development but does not impair junction formation.
Calì G; Zannini M; Rubini P; Tacchetti C; D'Andrea B; Affuso A; Wintermantel T; Boussadia O; Terracciano D; Silberschmidt D; Amendola E; De Felice M; Schütz G; Kemler R; Di Lauro R; Nitsch L
Endocrinology; 2007 Jun; 148(6):2737-46. PubMed ID: 17347311
[TBL] [Abstract][Full Text] [Related]
18. Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis.
van Staveren WC; Solís DW; Delys L; Venet D; Cappello M; Andry G; Dumont JE; Libert F; Detours V; Maenhaut C
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):413-8. PubMed ID: 16381821
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1 down-regulation of major histocompatibility complex class I in thyrocytes: coordinate regulation of two separate elements by thyroid-specific as well as ubiquitous transcription factors.
Napolitano G; Montani V; Giuliani C; Di Vincenzo S; Bucci I; Todisco V; Laglia G; Coppa A; Singer DS; Nakazato M; Kohn LD; Colletta G; Monaco F
Mol Endocrinol; 2000 Apr; 14(4):486-505. PubMed ID: 10770487
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J
Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
